# OraSure Pushes Operating Cash Flow Breakeven to Second Half of 2027

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/53726
Published: 2026-11-11T09:04:15.000Z
Updated: 2026-11-11T09:04:15.000Z
Section: Business

> The company expects $30 million to $32 million in revenue for Q4 2026, with gross margin near or slightly below its third-quarter level.

OraSure Technologies, Inc. now expects to reach operating cash flow breakeven in the second half of 2027, moving back a milestone it had previously expected at the start of 2027.

The company projects revenue of $30 million to $32 million for Q4 2026. It expects gross margin to be similar to or slightly below its third-quarter level. In the third quarter, OraSure expanded gross margins and reduced operating spending.

OraSure’s Ebola 2.0 test received emergency use authorization, and the company fulfilled initial orders. Its Colli-Pee Dx product has also launched.